Remove Communication Remove Information Remove Packaging
article thumbnail

STAT+: How the first over-the-counter birth control pill in the U.S. got its ‘unapologetic’ design

STAT

It’s not every day that a marketing team is tasked with designing the branding and packaging of the first over-the-counter birth control pill to be sold in the U.S.

Packaging 246
article thumbnail

Sustainable pharma packaging: breaking down the barriers to adoption

European Pharmaceutical Review

For most consumers, product packaging represents their first impression of a brand and its sustainability credentials. But how is this push shaping the pharma packaging market and what are the key changes we can expect to see? For many, aesthetic appeal and user experience top the list of priorities when it comes to packaging design.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

More on the Impact of the FDA RIFs: How Information Disclosure will Start FOIA-lling Behind

FDA Law Blog: Biosimilars

While much of the focus has been on how these cuts may impact application review timelines and industry engagement, see earlier post about the effect on generic drugs, another quieter consequence is emerging a significant slowdown in the availability of information that FDA is required to produce under the Freedom of Information Act (FOIA).

article thumbnail

Implications of RFK Jr.’s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry

PharmaTech

The decision was communicated through a Department of Health and Human Services (HHS) press release. It provides evidence-based recommendations on the use of vaccines for children and adults, informs decisions about insurance coverage, and helps determine eligibility for publicly funded programs such as Vaccines for Children (VFC).

article thumbnail

Design Considerations in Medical Device Packaging

Pharma Packaging Solutions

Medical device packaging plays a key role in ensuring the safety, efficacy, and integrity of medical devices from the point of manufacture to the end-user. At Tjoapack, we are a premier provider of top-tier medical device packaging services. The packaging must adhere to guidelines set by authorities such as the FDA and EU GMP.

article thumbnail

We, at OmniActive, invest over 10 per cent of the total outlay into R&D

Express Pharma

By providing clear information about our bioactives, we aim to boost consumer confidence, ultimately driving sales and improving profitability. At OmniActive, the emphasis is given to quality and efficacy through scientific validation, transparent communication, and credible endorsements.

Dosage 113
article thumbnail

Educating Patients about Generic Drugs: Strategies for Success

Drug Patent Watch

As healthcare professionals, it’s our responsibility to educate patients about generic drugs and empower them to make informed decisions about their treatment options. Mobile Apps Develop or recommend mobile apps that provide information about generic drugs, compare prices, and offer medication reminders.